SARS-CoV-2 - Prazosine - Therapeutic Candidates

SARS-CoV-2 - Prazosine - Therapeutic Candidates


Prazosin is an antihypertensive derived from quinazoline which belongs to the class of alpha-blockers. Prazosin is used to lower blood pressure by relaxing blood vessels. This action is due to the fact that prazosin is selective for alpha1 receptors on vascular smooth muscle. These receptors are responsible for the vasoconstrictive action of norepinephrine, which is responsible for raising blood pressure. Because of these effects, prazosin is indicated in the treatment of high blood pressure, anxiety and post-traumatic stress disorder and panic disorder.
A clinical study has begun to determine the potential of prazosin to slow and possibly prevent one of the worst effects of Covid-19, cytokine storm. This study was based on research in mice that showed that prazosin could prevent this cytokine storm phenomenon, as well as a study of a cohort of patients suffering from acute respiratory distress from a variety of causes.

Search result : 101 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 23
  • Biochemicals 74
  • Inhibitor/Antagonist/Agonist 26
  • Buffers and reagents 1
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
T22406-5mg
 5mg 
T22406-25mg
 25mg 
orb1225808-100mg
 100mg 
orb1309935-100mg
 100mg 
T63980-50mg
 50mg 
T63980-100mg
 100mg 
462926-2.5mg
 2.5mg 
462926-1mg
 1mg 
462926-10mg
 10mg 
abx282097-50mg
 50mg 
abx282097-250mg
 250mg 
M5894-5mg
 5mg 
M5894-25mg
 25mg 
M5894-10mg
 10mg 
T1050-100mg
 100mg 
019906-1mg
 1mg 
A11914-500
 500mg 
A11914-1000
 1000mg